Alpha Cognition Inc ACOG

$9.00 +0.15 (1.69%)

Valuation

Market cap
195,063,000
Revenue TTM
$10,220,000
Net income TTM
$-20,670,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
-202.25%
Debt to equity
0.00

Trading

Volume
269,600
Avg volume
115,704
Day's range
$8.58 – $9.10
Shares out
22,041,000
Stochastic %K
93%
Beta
2.32
Analysts
Strong Buy
Price target
$18.20

Price

Company profile

Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-se...

Show more

Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer's disease; ALPHA-1062 sublingual formulation; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mild traumatic brain injury; and ALPHA-0602, ALPHA-0702, and ALPHA-0802 programs for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis disease and spinal muscular atrophy. Alpha Cognition Inc. was founded in 2000 and is headquartered in Grapevine, Texas.

Industry
Biotechnology
Sector
Healthcare
Phone
858 344 4375
Website
https://www.alphacognition.com
Address
1452 Hughes Street, Suite 200, Grapevine, United States

Latest news

Stocktwits

ForestFoxes Nov 20, 6:26 AM
$ANVS CEO, Dr. Maccecchini speaks about her "science" ... Retail investors are in awe and bullish per Stocktwits' sentiment. But, the Market is bearish and reacts accordingly: -11.01% at closing - 2.46% lower after hours Some will say this is short sighted and only a one-day look. Results for those having held for the "Past 5 Years"? -97.24% Could it get worse than this? Yes. How do I know? Because I supported Dr. Maccecchini since 2021 and eventually signed a consultation agreement at which time this CEO shared the data she wanted to share with me and revealed insights into her very poorly and unprofessionally run company. WARNING: Do NOT support this company if you are seeking to aid a company in hopes of finding a cure. Tagging $ANVS $CGTX $ACOG $HIMS
3 replies
GeorgeJonesFan_In_Boston Nov 18, 8:07 PM
$ACOG good volume today, almost 227K. More tutes must be loading up
0 replies
Bioinvester001 Nov 12, 4:57 PM
$ACOG Raymond James just came out at $21.00.
0 replies
JackCampbell Nov 12, 12:18 PM
$ACOG H.C. Wainwright reiterates Buy with $20 (+132.02%) date: Nov 12, 2026
0 replies
StocktwitsEarnings Nov 11, 11:18 PM
$ACOG Q3 '26 Earnings Results & Recap Alpha Cognition reiterated full-year 2026 R&D and SG&A expense guidance of $50M to $54M; management also stated a goal of operating profitability in 2027.
0 replies
EarningsInsider Nov 11, 10:31 PM
https://www.marketbeat.com/earnings/reports/2026-11-11-alpha-cognition-inc-stock/ $ACOG Alpha Cognition Earnings Transcript
0 replies
Goodstockday Nov 11, 10:18 PM
$ACOG Solid earnings call. The new data should support growth in coming quarters. They have a strong presentation for insurance companies and physicians.
0 replies
JackCampbell Nov 11, 10:02 PM
$ACOG Q3 Earnings Beat: Net revenue surged to $7.8M (+30% QoQ / +230% YoY), driven by pure organic demand. Prescribers hit 2,410—crushing the full-year target early. Commercial execution is firing on all cylinders heading into 2027!
0 replies